Perl Jessica
SEC CIK 2043716 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | SVP, GC, Corp Sec | 165.3K | — | — | 5 | 2025-02-09 | 2026-04-29 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 16:27 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | Perl Jessica | SVP, GC, Corp Sec | A - Grant | $0.00 | +104.3K | 165.3K | +171% | $0 | |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $8.44 | -6,465 | 61.0K | -10% | -$54.6K |
| 2026-02-10 | 2026-02-09 | EBS | Emergent BioSolutions Inc. | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $11.03 | -918 | 67.5K | -1% | -$10.1K | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | Perl Jessica | SVP, GC, Corp Sec | A - Grant | $0.00 | +62.5K | 68.4K | +1,062% | $0 |
| 2025-02-11 | 2025-02-09 | EBS | Emergent BioSolutions Inc. | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $10.00 | -918 | 5,887 | -13% | -$9,180 |
Purchase Sale Sale after option exercise All abbreviations